Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer

CHF 103.95
Auf Lager
SKU
5E7CKPJBRPK
Stock 1 Verfügbar
Geliefert zwischen Mi., 24.12.2025 und Do., 25.12.2025

Details

This thesis focuses on the synthesis and vaccine evaluation of the prostate tumor- associated carbohydrate antigen RM2. The author first presents the use of the [1+2+3] one-pot sequential strategy to successfully synthesise the RM2 antigen and its analogues as single stereoisomers in every glycosylation step, producing good yields and stereoselectivity. He then introduces the conjugation of the synthetic RM2 antigen to the carrier protein CRM197 in an average number of 110 to create the prostate cancer vaccine candidate, which is combined with -galactosylceramide C1, its analogue C34, or Alu. The results of the vaccination studies in mice are also described and indicate that the strongest anti-RM2 antigen titer is exhibited when one molecule of diphtheria toxin (DT) is conjugated with an average of 4.7 molecules of RM2 antigen (DT-RM4.7) and adjuvanted with the glycolipid C34. More importantly, the induced mouse antibodies mediate the effective complement-dependent cytotoxicity (CDC) against the prostate cancer cell line LNCap. The study presented in this thesis is the first ever to successfully synthesize this complex glycan molecule. Owing to the steric hindrance of the adjacent sialyl moiety, the introduction of two sialic acid units to the compact and rigid 3,4 di branched galactoside unit is very challenging and the -selective and efficient glycosylation of the galactosamine moiety at the 4-position of di branched galactose is also problematic.


Nominated by National Taiwan University as an outstanding Ph.D. thesis Introduces the synthesis of RM2 antigen using the [1+2+3] one-pot sequential strategy Presents the preparation of vaccine candidates and the results of vaccination studies Includes total synthesis of a-(2 ? 3)/ a-(2 ? 6)-disialyl ganglioside derivatives as cancer-associated antigens Includes supplementary material: sn.pub/extras

Inhalt
Chemical Synthesis of Proposed RM2 and Derivatives.- RM2 Antigen: Structural Characterization and Determination of K D,surf for Multivalent Carbohydrate-Protein Interaction.- RM2 Antigen: Synthesis of Glycoconjugates.- Synthesis of the Heptasaccharide RM2 Prostate Tumor Antigen: Chemical Synthesis of Heptasaccharide and Tetrasaccharide (Inner Core of the RM2 Antigen).

Weitere Informationen

  • Allgemeine Informationen
    • GTIN 09783662526347
    • Lesemotiv Verstehen
    • Genre Chemistry
    • Auflage Softcover reprint of the original 1st edition 2015
    • Anzahl Seiten 124
    • Herausgeber Springer Berlin Heidelberg
    • Größe H235mm x B155mm x T7mm
    • Jahr 2016
    • EAN 9783662526347
    • Format Kartonierter Einband
    • ISBN 3662526344
    • Veröffentlichung 29.10.2016
    • Titel Synthesis and Vaccine Evaluation of the Tumor Associated Carbohydrate Antigen RM2 from Prostate Cancer
    • Autor Hong-Yang Chuang
    • Untertitel Springer Theses
    • Gewicht 224g
    • Sprache Englisch

Bewertungen

Schreiben Sie eine Bewertung
Nur registrierte Benutzer können Bewertungen schreiben. Bitte loggen Sie sich ein oder erstellen Sie ein Konto.
Made with ♥ in Switzerland | ©2025 Avento by Gametime AG
Gametime AG | Hohlstrasse 216 | 8004 Zürich | Schweiz | UID: CHE-112.967.470